Objective: The aim of this study is to compare the incidence of pulmonary embolism (PE) on computed tomography (CT) studies between younger and older patients to determine if there is an age-related bias for overutilization of CT pulmonary angiography (CTPA) in younger patients.
Results: The incidences of PE were 11.9% in males (A, 0%; B, 17.6%; C, 10%; D, 8.3%; E, 13.3%; F, 6.9%; G, 17.5%; H, 23.5%; I, 0%), 7.7% in females (A, 0%; B, 7.4%; C, 5.1%; D, 12.5%; E, 4.2%; F, 14.5%; G, 7.8%; H, 5.5%; I, 0%), and 9.4% in total patients (A, 0%; B, 11.1%; C, 6.8%; D, 11.1%; E, 7.5%; F, 10.5%; G, 11.5%; H, 9.7%; I, 0%). No significant differences in the incidences of PE were observed when patients were divided at the age of 40 (male, female, total; P = 1.0, 0.6252, 0.7220), at the age of 50 (male, female, total; P = 0.6748, 0.6879, 1.0), or at the age of 60 (male, female, total; P = 0.8458, 0.7046, 0.6820).
Conclusion:
No statistically significant difference in the incidence of PE was observed between younger and older patients. Our findings suggest that there is no age-related bias for overutilization of CT angiography (CTA) in younger patients.
Key Words: pulmonary, embolism, CT, radiation exposure (J Thorac Imaging 2006;21:167-171) R ecently, multidetector CT (MDCT) has become the modality of choice in patients with suspected pulmonary embolism (PE), which reflects positively on the advancement of CT technology. However, detection of PE is still often a challenge in a clinical setting, because the symptomatology of PE is nonspecific and chest radiographs in patients with PE may be normal. 1 Moreover, ventilation/perfusion scans have yielded inconclusive results on many occasions. Although rapid increase in utilization of MDCT for diagnosis of PE has been observed, 2,3 a major concern has been raised pertaining to radiation exposure. Radiation dose is a particularly serious issue in children and young adults owing to increased lifetime cancer risk. [4] [5] [6] [7] The proper indication for MDCT study and technical considerations to reduce radiation dose is now mandatory. 8 Recently, there has been concern for overutilization of MDCT scans in younger populations, especially in women of childbearing age. 9 To address this issue of potential overutilization of MDCT in young patients with suspected PE, we aimed to compare the incidence of PE between younger and older patients using a cohort of over 600 consecutive patients in our institution.
MATERIALS AND METHODS
Six hundred thirty-one consecutive CT pulmonary angiography (CTPA) cases for suspected acute PE between 11/10/2003 and 3/19/2004 were retrospectively studied with IRB approval of our research protocol. Of these 631 cases, 59 patients were found to have clots in the pulmonary arteries (ranging from the central to the subsegmental pulmonary artery) by reviewing reports. All CTPA studies were reported by board-certified radiologists. CTPA was performed using MDCT (4 detector rows, LightSpeed Qx/i, GE Medical Systems) at 1.25-mm collimation, 120 kVp, and 320 mA. Injection rate was 3.5 mL/s. Gender and age of the patients were obtained by a review of electronic medical records. Patients were and gender. The incidences of PE were calculated in each gender and age group based on radiology reports. To compare the incidence of PE between younger and older groups, they were further divided into 2 groups at the ages of 40 (<39 and Z40), 50 (<49 and Z50), and 60 (<59 and Z60). w 2 test was used to assess the difference between the younger and older groups for the incidence of PE. A P value of less than 0.05 was considered statistically significant.
RESULTS
Among the 631 persons suspected of having acute PE, a positive diagnosis was confirmed in 29 of 243 male patients and in 30 of 388 female patients. No patients positive for acute PE were found to be less than 20 years old or 90 years old or more among both males and females. The distribution of the numbers of patients studied and positive rates is shown in Figures 1 and 2 . The incidence of PE was not significantly different between males and females (P = 0.0916). The incidences of PE were 11.9% in male (A, 0%; B, 17.6%; C, 10%; D, 8.3%; E, 13.3%; F, 6.9%; G, 17.5%; H, 23.5%; I, 0%), 7.7% in female (A, 0%; B, 7.4%; C, 5.1%; D, 12.5%; E, 4.2%; F, 14.5%; G, 7.8%; H, 5.5%; I, 0%), and 9.4% in total patients (A, 0%; B, 11.1%; C, 6.8%; D, 11.1%; E, 7.5%; F, 10.5%; G, 11.5%; H, 9.7%; I, 0%) (Table 1 A-C). The incidence of PE divided by the cutoff ages of 40, 50, and 60 are summarized in Table 2 . No significant differences in the incidences of PE were observed when patients were divided at the age of 40 (male, female, total; P = 1.0, 0.6252, 0.7220), at the age of 50 (male, female, total; P = 0.6748, 0.6879, 1.0), or at the age of 60 (male, female, total; P = 0.8458, 0.7046, 0.6820) ( Table 2) .
DISCUSSION
No significant differences in the incidence of PE between younger and older groups in male, female, and combined patient populations were observed. The evidence of overutilization of MDCT for detecting PE was not observed in younger patients at our institution.
To our knowledge, there has been no previous report of age-related incidences of PE by CTPA, especially focusing on an overutilization of CTPA in young patients.
No positive patients were found to be less than 20 years old or 90 years old or more in both male and female groups. The reason for this result may be that our study population was relatively small and a department of pediatrics had not opened at our hospital as yet. No significant difference in the incidence of PE was observed between males and females. The incidence of PE has been previously reported to be higher in females than in males. 1, 3 Although this was not the case in our study, the small size of our study cohort may be the cause of this discrepancy.
Radiation dose is a serious issue in children and young adults because of relatively increased lifetime cancer risk. 4, 6, 7 CT dose reduction requires a combination of approaches, which include user education for physicians and radiologic technologists, updated dosimetry charts by medical physicists, and the development of automatic exposure control devices by scanner manufacturers. 8 Donnelly et al 4 emphasized that tube current and pitch, which can be adjusted easily, have a profound effect on radiation dose.
Recently, 2 articles have addressed radiation exposure of helical CT for detecting PE compared with pulmonary angiography. 10, 11 Kuiper et al reports that the average effective doses for MDCT angiography (4 detector rows) of the pulmonary arteries (27 patines) and for pulmonary digital subtraction angiography (DSA) were 4.2 mSv (range 2.2 to 6.0 mSv) and 7.1 mSv (range 3.3 to 17.3 mSv), respectively. They conclude that the effective dose in MDCT angiography studies for PE is slightly lower than that in pulmonary DSA. 10 Resten et al 11 report that the radiation dose was 5 times smaller at CT than at DSA for detection of PE (single-detector helical CT; 6.4+1.5 mGy, pulmonary angiography; 28.0+7.6 mGy). CTPA has been rapidly replacing pulmonary angiography because of its easier availability, high diagnostic accuracy, and relatively lower radiation dose compared with conventional pulmonary angiography; however, Diederich et al 9 warn against overutilization of CT for detecting PE.
Pulmonary embolus is a leading cause of maternal mortality and has been reported to occur in 0.5 to 3.0 of 1000 pregnancies. 12, 13 Increased venous stasis is the most important factor, but prolonged bed rest, pregnancyrelated hypercoagulability, decreased fibrinolysis, and familial predisposition are also implicated.
14 Radiation dose is always a concern in CTPA and ventilationperfusion scintigraphy in pregnant patients. WinerMuram et al 15 conclude that the average fetal radiation dose with helical CT is less than that with ventilationperfusion scintigraphy throughout all trimesters. The condition of pregnancy should not preclude use of helical CT for the diagnosis of PE. However, alternative methods with less or no radiation exposure, such as sonography, MR imaging, or D-dimer, should always be considered.
It is still challenging to make a diagnosis of PE solely on the basis of clinical symptoms and signs. Arima et al 16 report gradual onset, coagulopathy, and clinical sign of deep venous thrombosis are more often seen in younger patients than in older patients. Timmons et al 17 showed that older persons complained less often of pleuritic chest pain, and were more often cyanosed and hypoxic than younger persons.
Our study has some limitations. Our data depended on the reports. Actual incidence of PE was not cleared in our cohort study. Moreover, there was no interobserver agreement. However, a patient who needed further investigation for confirming the diagnosis of acute PE was shifted from other patients who complainted of nonspecific symptoms by using CTPA, which was used as a first choice of imaging modality. We assumed that the low incidence of acute PE in younger patients based on the reports represents a high incidence of an uncritical request for CTPA from clinicians. At this point, we believe that the incidence based on the reports was reasonable.
In conclusion, no statistically significant difference in the incidence of PE was observed between younger and older patients. Our findings suggest that there is no agerelated bias for overutilization of CTA in younger patients. 
